ZUM WIRKUNGSMECHANISMUS VON BENCYCLAN AN DER GLATTEN MUSKULATUR

Translated title of the contribution: Mechanism of action of bencyclane on smooth muscle

W. R. Kukovetz, G. Poch, S. Holzmann, Elisabeth M. Paietta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Bencyclane (N [3 (1 benzyl cycloheptyloxy) propyl] N,N dimethyl amine hydrogenfumarate, Fludilat), inhibits phosphodiesterase (PDE) activity in vitro similarly to several other smooth muscle relaxants. Compared with papaverine this inhibitory effect of bencyclane on PDE is weak despite its strong relaxant effect on smooth muscle, which is about equal to that of papaverine. 14C Bencyclane is accumulated 8 fold in the smooth muscle tissue of bovine coronary arteries, indicating that relaxation is caused by 8 fold higher concentrations in the tissue than in the organ bath. A comparison of (corrected) ED50 values for relaxation with K(i) values for PDE inhibition obtained with several PDE inhibitors, including bencyclane, yields a significant correlation between both parameters. Since in subsequent studies in isolated tracheal muscle strips, bencyclane at maximum relaxing concentrations did not increase cAMP, which was in contrast to the actions of papaverine or aminophylline, it is likely that bencyclane induced smooth muscle relaxation is unrelated to inhibition of PDE or cAMP. In the same dose range in which bencyclane relaxes smooth muscles it exerts a nonspecific antiadrenergic inhibitory effect, possibly due to its local anesthetic action at the cell membrane. It is also possible that the myocardial inhibitory effect of bencyclane is caused by a direct Ca++ antagonistic mechanism.

Original languageGerman
Pages (from-to)722-726
Number of pages5
JournalArzneimittel-Forschung/Drug Research
Volume25
Issue number5
StatePublished - 1975
Externally publishedYes

Fingerprint

Bencyclane
Smooth Muscle
Muscle
Phosphoric Diester Hydrolases
Papaverine
Tissue
Aminophylline
Muscles
Adrenergic Antagonists
Muscle Relaxation
Phosphodiesterase Inhibitors
Cell membranes
Local Anesthetics
Baths
Amines
Coronary Vessels

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

ZUM WIRKUNGSMECHANISMUS VON BENCYCLAN AN DER GLATTEN MUSKULATUR. / Kukovetz, W. R.; Poch, G.; Holzmann, S.; Paietta, Elisabeth M.

In: Arzneimittel-Forschung/Drug Research, Vol. 25, No. 5, 1975, p. 722-726.

Research output: Contribution to journalArticle

Kukovetz, W. R. ; Poch, G. ; Holzmann, S. ; Paietta, Elisabeth M. / ZUM WIRKUNGSMECHANISMUS VON BENCYCLAN AN DER GLATTEN MUSKULATUR. In: Arzneimittel-Forschung/Drug Research. 1975 ; Vol. 25, No. 5. pp. 722-726.
@article{3bfcb5d8ab814a8eaedb4acf7761cb66,
title = "ZUM WIRKUNGSMECHANISMUS VON BENCYCLAN AN DER GLATTEN MUSKULATUR",
abstract = "Bencyclane (N [3 (1 benzyl cycloheptyloxy) propyl] N,N dimethyl amine hydrogenfumarate, Fludilat), inhibits phosphodiesterase (PDE) activity in vitro similarly to several other smooth muscle relaxants. Compared with papaverine this inhibitory effect of bencyclane on PDE is weak despite its strong relaxant effect on smooth muscle, which is about equal to that of papaverine. 14C Bencyclane is accumulated 8 fold in the smooth muscle tissue of bovine coronary arteries, indicating that relaxation is caused by 8 fold higher concentrations in the tissue than in the organ bath. A comparison of (corrected) ED50 values for relaxation with K(i) values for PDE inhibition obtained with several PDE inhibitors, including bencyclane, yields a significant correlation between both parameters. Since in subsequent studies in isolated tracheal muscle strips, bencyclane at maximum relaxing concentrations did not increase cAMP, which was in contrast to the actions of papaverine or aminophylline, it is likely that bencyclane induced smooth muscle relaxation is unrelated to inhibition of PDE or cAMP. In the same dose range in which bencyclane relaxes smooth muscles it exerts a nonspecific antiadrenergic inhibitory effect, possibly due to its local anesthetic action at the cell membrane. It is also possible that the myocardial inhibitory effect of bencyclane is caused by a direct Ca++ antagonistic mechanism.",
author = "Kukovetz, {W. R.} and G. Poch and S. Holzmann and Paietta, {Elisabeth M.}",
year = "1975",
language = "German",
volume = "25",
pages = "722--726",
journal = "Drug Research",
issn = "2194-9379",
publisher = "Thieme",
number = "5",

}

TY - JOUR

T1 - ZUM WIRKUNGSMECHANISMUS VON BENCYCLAN AN DER GLATTEN MUSKULATUR

AU - Kukovetz, W. R.

AU - Poch, G.

AU - Holzmann, S.

AU - Paietta, Elisabeth M.

PY - 1975

Y1 - 1975

N2 - Bencyclane (N [3 (1 benzyl cycloheptyloxy) propyl] N,N dimethyl amine hydrogenfumarate, Fludilat), inhibits phosphodiesterase (PDE) activity in vitro similarly to several other smooth muscle relaxants. Compared with papaverine this inhibitory effect of bencyclane on PDE is weak despite its strong relaxant effect on smooth muscle, which is about equal to that of papaverine. 14C Bencyclane is accumulated 8 fold in the smooth muscle tissue of bovine coronary arteries, indicating that relaxation is caused by 8 fold higher concentrations in the tissue than in the organ bath. A comparison of (corrected) ED50 values for relaxation with K(i) values for PDE inhibition obtained with several PDE inhibitors, including bencyclane, yields a significant correlation between both parameters. Since in subsequent studies in isolated tracheal muscle strips, bencyclane at maximum relaxing concentrations did not increase cAMP, which was in contrast to the actions of papaverine or aminophylline, it is likely that bencyclane induced smooth muscle relaxation is unrelated to inhibition of PDE or cAMP. In the same dose range in which bencyclane relaxes smooth muscles it exerts a nonspecific antiadrenergic inhibitory effect, possibly due to its local anesthetic action at the cell membrane. It is also possible that the myocardial inhibitory effect of bencyclane is caused by a direct Ca++ antagonistic mechanism.

AB - Bencyclane (N [3 (1 benzyl cycloheptyloxy) propyl] N,N dimethyl amine hydrogenfumarate, Fludilat), inhibits phosphodiesterase (PDE) activity in vitro similarly to several other smooth muscle relaxants. Compared with papaverine this inhibitory effect of bencyclane on PDE is weak despite its strong relaxant effect on smooth muscle, which is about equal to that of papaverine. 14C Bencyclane is accumulated 8 fold in the smooth muscle tissue of bovine coronary arteries, indicating that relaxation is caused by 8 fold higher concentrations in the tissue than in the organ bath. A comparison of (corrected) ED50 values for relaxation with K(i) values for PDE inhibition obtained with several PDE inhibitors, including bencyclane, yields a significant correlation between both parameters. Since in subsequent studies in isolated tracheal muscle strips, bencyclane at maximum relaxing concentrations did not increase cAMP, which was in contrast to the actions of papaverine or aminophylline, it is likely that bencyclane induced smooth muscle relaxation is unrelated to inhibition of PDE or cAMP. In the same dose range in which bencyclane relaxes smooth muscles it exerts a nonspecific antiadrenergic inhibitory effect, possibly due to its local anesthetic action at the cell membrane. It is also possible that the myocardial inhibitory effect of bencyclane is caused by a direct Ca++ antagonistic mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0016812116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016812116&partnerID=8YFLogxK

M3 - Article

C2 - 170943

AN - SCOPUS:0016812116

VL - 25

SP - 722

EP - 726

JO - Drug Research

JF - Drug Research

SN - 2194-9379

IS - 5

ER -